Excerpt and interpretation of the Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease in 2025
- VernacularTitle:《2025年亚太肝病学会临床实践指南： 代谢相关脂肪性肝病的诊断和管理》摘译与解读
- Author:
Siyi LEI
1
;
Liyou LIAN
1
;
Minghua ZHENG
1
Author Information
- Publication Type:Journal Article
- Keywords: Metabolic Dysfunction-Associated Fatty Liver Disease; Diagnosis; Therapeutics; Practice Guideline
- From: Journal of Clinical Hepatology 2025;41(6):1043-1052
- CountryChina
- Language:Chinese
- Abstract: Since the Asia-Pacific Association for the Study of the Liver （APASL） issued the clinical practice guidelines for metabolic associated fatty liver disease （MAFLD） in 2020， the research on MAFLD has been further deepened. Therefore， APASL has made comprehensive updates and revisions based on the previous guidelines， and the latest version of the clinical practice guidelines for diagnosis and management of MAFLD， which was released in February 2025， has updated the epidemiology， screening， assessment， and treatment of MAFLD， aiming to promote the clinical practice， knowledge popularization， and scientific research of MAFLD. This article makes an excerpt and an interpretation of the updated key points of the guidelines.
